Cargando…

Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer

BACKGROUND: Intra-tumoral heterogeneity has been recently addressed in different types of cancer, including breast cancer. A concept describing the origin of intra-tumoral heterogeneity is the cancer stem-cell hypothesis, proposing the existence of cancer stem cells that can self-renew limitlessly a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kündig, Pascale, Giesen, Charlotte, Jackson, Hartland, Bodenmiller, Bernd, Papassotirolopus, Bärbel, Freiberger, Sandra Nicole, Aquino, Catharine, Opitz, Lennart, Varga, Zsuzsanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941467/
https://www.ncbi.nlm.nih.gov/pubmed/29739401
http://dx.doi.org/10.1186/s12967-018-1495-6
_version_ 1783321291130929152
author Kündig, Pascale
Giesen, Charlotte
Jackson, Hartland
Bodenmiller, Bernd
Papassotirolopus, Bärbel
Freiberger, Sandra Nicole
Aquino, Catharine
Opitz, Lennart
Varga, Zsuzsanna
author_facet Kündig, Pascale
Giesen, Charlotte
Jackson, Hartland
Bodenmiller, Bernd
Papassotirolopus, Bärbel
Freiberger, Sandra Nicole
Aquino, Catharine
Opitz, Lennart
Varga, Zsuzsanna
author_sort Kündig, Pascale
collection PubMed
description BACKGROUND: Intra-tumoral heterogeneity has been recently addressed in different types of cancer, including breast cancer. A concept describing the origin of intra-tumoral heterogeneity is the cancer stem-cell hypothesis, proposing the existence of cancer stem cells that can self-renew limitlessly and therefore lead to tumor progression. Clonal evolution in accumulated single cell genomic alterations is a further possible explanation in carcinogenesis. In this study, we addressed the question whether intra-tumoral heterogeneity can be reliably detected in tissue-micro-arrays in breast cancer by comparing expression levels of conventional predictive/prognostic tumor markers, tumor progression markers and stem cell markers between central and peripheral tumor areas. METHODS: We analyzed immunohistochemical expression and/or gene amplification status of conventional prognostic tumor markers (ER, PR, HER2, CK5/6), tumor progression markers (PTEN, PIK3CA, p53, Ki-67) and stem cell markers (mTOR, SOX2, SOX9, SOX10, SLUG, CD44, CD24, TWIST) in 372 tissue-micro-array samples from 72 breast cancer patients. Expression levels were compared between central and peripheral tumor tissue areas and were correlated to histopathological grading. 15 selected cases additionally underwent RNA sequencing for transcriptome analysis. RESULTS: No significant difference in any of the analyzed between central and peripheral tumor areas was seen with any of the analyzed methods/or results that showed difference. Except mTOR, PIK3CA and SOX9 (nuclear) protein expression, all markers correlated significantly (p < 0.05) with histopathological grading both in central and peripheral areas. CONCLUSION: Our results suggest that intra-tumoral heterogeneity of stem-cell and tumor-progression markers cannot be reliably addressed in tissue-micro-array samples in breast cancer. However, most markers correlated strongly with histopathological grading confirming prognostic information as expression profiles were independent on the site of the biopsy was taken. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-018-1495-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5941467
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59414672018-05-14 Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer Kündig, Pascale Giesen, Charlotte Jackson, Hartland Bodenmiller, Bernd Papassotirolopus, Bärbel Freiberger, Sandra Nicole Aquino, Catharine Opitz, Lennart Varga, Zsuzsanna J Transl Med Research BACKGROUND: Intra-tumoral heterogeneity has been recently addressed in different types of cancer, including breast cancer. A concept describing the origin of intra-tumoral heterogeneity is the cancer stem-cell hypothesis, proposing the existence of cancer stem cells that can self-renew limitlessly and therefore lead to tumor progression. Clonal evolution in accumulated single cell genomic alterations is a further possible explanation in carcinogenesis. In this study, we addressed the question whether intra-tumoral heterogeneity can be reliably detected in tissue-micro-arrays in breast cancer by comparing expression levels of conventional predictive/prognostic tumor markers, tumor progression markers and stem cell markers between central and peripheral tumor areas. METHODS: We analyzed immunohistochemical expression and/or gene amplification status of conventional prognostic tumor markers (ER, PR, HER2, CK5/6), tumor progression markers (PTEN, PIK3CA, p53, Ki-67) and stem cell markers (mTOR, SOX2, SOX9, SOX10, SLUG, CD44, CD24, TWIST) in 372 tissue-micro-array samples from 72 breast cancer patients. Expression levels were compared between central and peripheral tumor tissue areas and were correlated to histopathological grading. 15 selected cases additionally underwent RNA sequencing for transcriptome analysis. RESULTS: No significant difference in any of the analyzed between central and peripheral tumor areas was seen with any of the analyzed methods/or results that showed difference. Except mTOR, PIK3CA and SOX9 (nuclear) protein expression, all markers correlated significantly (p < 0.05) with histopathological grading both in central and peripheral areas. CONCLUSION: Our results suggest that intra-tumoral heterogeneity of stem-cell and tumor-progression markers cannot be reliably addressed in tissue-micro-array samples in breast cancer. However, most markers correlated strongly with histopathological grading confirming prognostic information as expression profiles were independent on the site of the biopsy was taken. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-018-1495-6) contains supplementary material, which is available to authorized users. BioMed Central 2018-05-08 /pmc/articles/PMC5941467/ /pubmed/29739401 http://dx.doi.org/10.1186/s12967-018-1495-6 Text en © The Author(s) 2018, corrected publication July 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Kündig, Pascale
Giesen, Charlotte
Jackson, Hartland
Bodenmiller, Bernd
Papassotirolopus, Bärbel
Freiberger, Sandra Nicole
Aquino, Catharine
Opitz, Lennart
Varga, Zsuzsanna
Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer
title Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer
title_full Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer
title_fullStr Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer
title_full_unstemmed Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer
title_short Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer
title_sort limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941467/
https://www.ncbi.nlm.nih.gov/pubmed/29739401
http://dx.doi.org/10.1186/s12967-018-1495-6
work_keys_str_mv AT kundigpascale limitedutilityoftissuemicroarraysindetectingintratumoralheterogeneityinstemcellcharacteristicsandtumorprogressionmarkersinbreastcancer
AT giesencharlotte limitedutilityoftissuemicroarraysindetectingintratumoralheterogeneityinstemcellcharacteristicsandtumorprogressionmarkersinbreastcancer
AT jacksonhartland limitedutilityoftissuemicroarraysindetectingintratumoralheterogeneityinstemcellcharacteristicsandtumorprogressionmarkersinbreastcancer
AT bodenmillerbernd limitedutilityoftissuemicroarraysindetectingintratumoralheterogeneityinstemcellcharacteristicsandtumorprogressionmarkersinbreastcancer
AT papassotirolopusbarbel limitedutilityoftissuemicroarraysindetectingintratumoralheterogeneityinstemcellcharacteristicsandtumorprogressionmarkersinbreastcancer
AT freibergersandranicole limitedutilityoftissuemicroarraysindetectingintratumoralheterogeneityinstemcellcharacteristicsandtumorprogressionmarkersinbreastcancer
AT aquinocatharine limitedutilityoftissuemicroarraysindetectingintratumoralheterogeneityinstemcellcharacteristicsandtumorprogressionmarkersinbreastcancer
AT opitzlennart limitedutilityoftissuemicroarraysindetectingintratumoralheterogeneityinstemcellcharacteristicsandtumorprogressionmarkersinbreastcancer
AT vargazsuzsanna limitedutilityoftissuemicroarraysindetectingintratumoralheterogeneityinstemcellcharacteristicsandtumorprogressionmarkersinbreastcancer